EP 0856000 A1 19980805 - 1,3,5-TRISUBSTITUTED PYRAZOLES FOR TREAMENT OF INFLAMMATION
Title (en)
1,3,5-TRISUBSTITUTED PYRAZOLES FOR TREAMENT OF INFLAMMATION
Title (de)
1,3,5-TRISUBSTITUIERTE PYRAZOLE ZUR BEHANDLUNG VON ENTZÜNDUNGEN
Title (fr)
PYRAZOLES 1,3,5-TRISUBSTITUES POUR LE TRAITEMENT DES INFLAMMATIONS
Publication
Application
Priority
- GB 9520584 A 19951009
- JP 9602919 W 19961008
Abstract (en)
[origin: WO9713755A1] A compound of the formula (I) wherein R<1> is hydroxyethyl, 1-hydroxy-1-methylethyl, hydrogen, halogen, nitro, or cyano, R<2> is chloro, cyano, or lower alkyl optionally substituted with halogen, and R<3> is lower alkylthio, lower alkylsulfinyl, or lower alkylsulfonyl, provided that when R<1> is hydrogen, halogen, nitro, or cyano, then R<2> is chloro, and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/415 (2006.01); A61P 29/00 (2006.01); C07D 231/12 (2006.01); C07D 231/14 (2006.01); C07D 231/16 (2006.01)
CPC (source: EP KR)
A61K 31/415 (2013.01 - KR); A61P 29/00 (2017.12 - EP); C07D 231/12 (2013.01 - EP KR); C07D 231/14 (2013.01 - EP KR); C07D 231/16 (2013.01 - EP KR)
Citation (search report)
See references of WO 9713755A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9713755 A1 19970417; AU 7146196 A 19970430; CA 2234511 A1 19970417; CN 1203589 A 19981230; EP 0856000 A1 19980805; GB 9520584 D0 19951213; JP H11513403 A 19991116; KR 19990063989 A 19990726; ZA 968286 B 19970513
DOCDB simple family (application)
JP 9602919 W 19961008; AU 7146196 A 19961008; CA 2234511 A 19961008; CN 96198649 A 19961008; EP 96932841 A 19961008; GB 9520584 A 19951009; JP 51490997 A 19961008; KR 19980702464 A 19980403; ZA 968286 A 19961002